The increased glutamine stimulates the brain, preventing deep, refreshing levels of sleep, which results in fatigue the next day
Experimental evidence is ongoing to explore and unravel all these possible beneficial mechanisms, while the combination of both drug categories (at least in patients with T2D) with or without other therapeutic strategies seems promising
Based on data derived from our previous study [8], inclusion of 16 participants was calculated to provide at least 90% power (at = 0.01 to allow for subgroup comparisons) to detect a 20% difference in glucose iAUC 0120min between metformin treatments and the control
GLP-1 medications such as Tirzepatide and Semaglutide work by reducing appetite, controlling cravings, improving fullness, and helping the body use energy more efficiently leading to steady, sustainable fat loss without restrictive diets or surgery
Additional research areas include Epithalon's effects on gene expression patterns associated with aging
Premature ovarian failure is another recognized comorbidity